A new approach to detecting cancer earlier from blood tests: Study
(University Health Network) Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined 'liquid biopsy,' epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Research on imaging in radiation oncology featured in Red Journal special issue
(American Society for Radiation Oncology) A new special edition of the International Journal of Radiation Oncology* Biology* Physics (Red Journal) focuses on the roles of imaging in radiation oncology. The collection explores topics such as improving accuracy with patient positioning, defining radiation therapy volumes using imaging, imaging of functional biomarkers, the role of imaging in post-treatment care, machine learning and artificial intelligence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Researchers identify a mechanism that fuels cancer cells' growth
(University of California - Los Angeles Health Sciences) The study, led by UCLA professors Claudio Scafoglio and David Shackelford, suggests that a biomarker can help scientists detect lung cancer earlier, when it is much easier to treat. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

'Hopeful technology' could change detection, diagnosis of deadly ovarian cancer
(Washington University in St. Louis) Ovarian cancer claims the lives of more than 14,000 women in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University has found an innovative way to use sound and light to diagnose ovarian tumors, which may lead to a promising new diagnostic imaging technique to improve current standard of care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

St. Jude announces extensive resource to advance leukemia research
(St. Jude Children's Research Hospital) The effort, called PROPEL (Public Resource of Patient-derived and Expanded Leukemias), aims to advance fundamental research on the biology of leukemia and to help develop cures by sharing unique patient-derived xenograft samples with researchers around the world. PROPEL samples are available free of charge to researchers with no obligation to collaborate. The initiative is the latest effort by St. Jude to advance cures by sharing extensive data samples with the global scientific community. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Ralph DeBerardinis recognized for for changing our understanding of cancer
(The Academy of Medicine, Engineering& Science of Texas) Ralph DeBerardinis, M.D., Ph.D., professor at the Children's Medical Center Research Institute at UT Southwestern (CRI) is the recipient of the 2019 Edith and Peter O'Donnell Award in Medicine from TAMEST (The Academy of Medicine, Engineering and Science of Texas). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Investigational drug shows promising results in Phase II study of aggressive, often fatal blood disorder with no approved therapies
(University of Texas M. D. Anderson Cancer Center) A Phase I/II study, led by investigators at The University of Texas MD Anderson Cancer Center, reports an investigational drug called tagraxofusp has demonstrated high response rates in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare but highly aggressive -- and often fatal bone marrow and blood disorder -- for which there are no existing approved therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Rainforest vine compound starves pancreatic cancer cells
(American Chemical Society) Pancreatic cancer cells are known for their ability to thrive under extreme conditions of low nutrients and oxygen, a trait known in the cancer field as 'austerity.' The cells' remarkable resistance to starvation is one reason why pancreatic cancer is so deadly. Now researchers have identified a compound from a Congolese plant that has strong " antiausterity " potential, making pancreatic cancer cells susceptible to nutrient starvation. They report their results in ACS' Journal of Natural Products. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Clinical trial harnesses power of natural killer cells to treat neuroblastoma
(Solving Kids' Cancer) Researchers use a humanized monoclonal antibody known as hu14.18-IL2, which specifically targets neuroblastoma tumor cells and binds to them. The humanized monoclonal antibody may be more effective at activating the NK cells for killing the cancer cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2018 Category: International Medicine & Public Health Source Type: news

Is the golden spice a golden cure? Woman, 67, beat blood cancer after stopping traditional treatments and using TURMERIC
(Natural News) A 67-year-old woman from London, England has reportedly put an end to her years-long battle with blood cancer with turmeric. Doctors reportedly claim to have never seen anything like this before, where medicinal plant compounds have actually cured someone’s cancer. Formally known as myeloma, this type of cancer is formed by malignant plasma... (Source: NaturalNews.com)
Source: NaturalNews.com - November 14, 2018 Category: Consumer Health News Source Type: news

WATCH: Nurses give breast milk to mom with breast cancer
A pay it forward chain that began with two nurses in an Indianapolis has allowed a mother of three battling breast cancer to feed her 10-month-old daughter breast milk. (Source: ABC News: Health)
Source: ABC News: Health - November 14, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Vitamin C can prevent gout
(Natural News) Vitamin C has been reported to prevent and treat infection, heart disease, diabetes, and cancer. Another study has shown that it can also prevent gout. Gout is one of the most common types of arthritis that causes severe pain, swelling, and stiffness in a joint, typically affecting the joint in the big toe.... (Source: NaturalNews.com)
Source: NaturalNews.com - November 14, 2018 Category: Consumer Health News Source Type: news

Teenage Obesity May Raise Pancreatic Cancer Risk Years Later
(Source: Cancercompass News: Pancreatic Cancer)
Source: Cancercompass News: Pancreatic Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Teenage Obesity May Raise Pancreatic Cancer Risk Years Later
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 14, 2018 Category: Cancer & Oncology Source Type: news

Better access to psychological support needed for dieters
‘Obesity is not a choice’, and fat shaming is unhelpful Related items fromOnMedica What promotes uptake and retention in group-based weight management services? Novel imagery technique boosts weight loss GPs should lead on weight management advice to children Severe mental illness linked to poorer physical health Adolescent obesity linked to higher pancreatic cancer risk in adulthood (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 14, 2018 Category: UK Health Source Type: news

FDA fast tracks Roche triple-negative breast cancer treatment
If approved, this Tecentriq combination would be the first cancer immunotherapy regimen for the treatment of PD-L1-positive, metastatic triple-negative breast cancer (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 13, 2018 Category: Pharmaceuticals Source Type: news

Mailed HPV Tests Help Identify Women At Risk for Cervical Cancer Mailed HPV Tests Help Identify Women At Risk for Cervical Cancer
Kits to self-test for human papillomavirus (HPV) mailed to underserved women helped to identify virtually all of those with high-risk HPV oncogenic types, in a proof-of-principle study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

App Cuts Cancer Pain; Immune Tx Side Effects; Gaps in Goals of Care
(MedPage Today) -- Highlights from the Palliative and Supportive Care in Oncology Symposium (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 13, 2018 Category: Hematology Source Type: news

Three female tech entrepreneurs get real – from self-doubt to breast cancer
Three female tech entrepreneurs shared their entrepreneurial journeys Monday evening, from dealing with self-doubt to running a business during breast cancer treatment. The local entrepreneurs who spoke as part of Global Entrepreneurship Week:  Dr. Kim Gandy is CEO and founder of Play-it Health, which developed an adherence platform with incentives for transplant patients and those with chronic conditions. Linda Van Horn is CEO and founder of iShare Medical, wh ich provides secure, HIPAA-compliant… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2018 Category: Biotechnology Authors: Leslie Collins Source Type: news

Three female tech entrepreneurs get real – from self-doubt to breast cancer
Three female tech entrepreneurs shared their entrepreneurial journeys Monday evening, from dealing with self-doubt to running a business during breast cancer treatment. The local entrepreneurs who spoke as part of Global Entrepreneurship Week:  Dr. Kim Gandy is CEO and founder of Play-it Health, which developed an adherence platform with incentives for transplant patients and those with chronic conditions. Linda Van Horn is CEO and founder of iShare Medical, wh ich provides secure, HIPAA-compliant… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2018 Category: Pharmaceuticals Authors: Leslie Collins Source Type: news

Nurses donate breast milk to mom with breast cancer
Kata Carter was diagnosed with breast cancer when her youngest daughter was three-months-old. (Source: ABC News: Health)
Source: ABC News: Health - November 13, 2018 Category: Consumer Health News Tags: GMA Source Type: news

The Verdict on IMRT Plus Doxorubicin in Unresectable Thyroid Cancer
A study inThyroid evaluated the safety and efficacy of concurrent intensity-modulated radiation therapy and doxorubicin in thyroid cancer. (Source: CancerNetwork)
Source: CancerNetwork - November 13, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

ALA lung cancer screening campaign targets Hispanics
The American Lung Association (ALA) Lung Force initiative and the Ad Council...Read more on AuntMinnie.comRelated Reading: Groups release guide for new CT lung screening programs IASLC advocates CT lung cancer screening New decision aids may revamp CT lung cancer screening Are patients adequately informed about CT lung screening? New studies highlight promises, risks of lung cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 13, 2018 Category: Radiology Source Type: news

Losartan Latest BP Drug Recalled for Contamination
NDEA is found naturally in certain foods, drinking water, air pollution, and industrial processes, and it may cause cancer, according to the International Agency for Research on Cancer. (Source: WebMD Health)
Source: WebMD Health - November 13, 2018 Category: Consumer Health News Source Type: news

AMA Urges Coverage for Added Breast Cancer Screening
(MedPage Today) -- Resolution aimed at women with dense breasts (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - November 13, 2018 Category: Hematology Source Type: news

40 Under Forty: Georgia Comprehensive Cancer Control Program's Tamira Moon
Moon is a member of the 2018 class of 40 Under Forty honorees. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 13, 2018 Category: American Health Source Type: news

Mesothelioma Patients Can Benefit from Genetic Testing
All patients diagnosed with malignant mesothelioma should undergo genetic testing to better identify the most appropriate treatment plan, according to Dr. Michele Carbone, the director of thoracic oncology at the University of Hawaii Cancer Center. Genetic testing also could lead to a more accurate prognosis and help family members determine if they are more susceptible to the cancer. Carbone estimates only one-third of all mesothelioma patients today have undergone the testing. “Some of these patients could definitely benefit from genetic testing,” Carbone told The Mesothelioma Center at Asbestos.com. Carbon...
Source: Asbestos and Mesothelioma News - November 13, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

At ESMO, New Data on Managing Long-term Immunotherapy Responders At ESMO, New Data on Managing Long-term Immunotherapy Responders
Despite closely following the 2018 World Conference on Lung Cancer, this year's annual congress of the European Society for Medical Oncology offered important immunotherapy data in lung cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

3rd blood pressure drug, losartan, recalled in recent weeks over impurity
For the third time in recent weeks, a blood pressure medication has been recalled because it may have been contaminated with an agent linked to cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 13, 2018 Category: Consumer Health News Source Type: news

Two-pronged device enables immune cells to identify and kill cancers
Immune cells called Gamma Delta T cells can act independently to identify and kill cancer cells, defying the conventional view of the immune system, reveals new research. (Source: Medical Research Council General News)
Source: Medical Research Council General News - November 13, 2018 Category: Research Source Type: news

HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Developing Targeted Therapies With Potential Applicability Across Many Cancer Types GUILDFORD, England, November 13, 2018 -- (Healthcare Sales & Marketing Network) -- HOX Therapeutics, the private biotechnology company developing first-in-class, highly... Biopharmaceuticals, Oncology, Personnel HOX Therapeutics, HOX genes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Novartis' $4 Million Gene Therapy -- Real Price Or A Negotiation Ploy?
We are in a wondrous age of medicine where CURES for certain types of cancer, rare diseases, blindness and other scourges are imminent. We now need to figure out how to pay for them. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 13, 2018 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NASDAQ:AVXS NYSE:NVS Source Type: news

AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention
TUESDAY, Nov. 13, 2018 -- Omega-3 fatty acids and vitamin D do not significantly reduce major cardiovascular events or cancer incidence, according to two studies published online Nov. 10 in the New England Journal of Medicine to coincide with the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Coordinated Care Needed for Cancer Survivors, Caregivers
TUESDAY, Nov. 13, 2018 -- There is an urgent need for coordinated, comprehensive, personalized care for cancer survivors and caregivers, according to a report published online Oct. 30 in CA: A Cancer Journal for Clinicians. Catherine M. Alfano,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Atlas Ventures startup Kymera Therapeutics lands $65M investment round
Cambridge startup Kymera Therapeutics Inc. has closed a $65 million Series B venture capital round Tuesday that will support the company as it prepares its first cancer and inflammatory disease drugs for the clinic. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2018 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Atlas Ventures startup Kymera Therapeutics lands $65M investment round
Cambridge startup Kymera Therapeutics Inc. has closed a $65 million Series B venture capital round Tuesday that will support the company as it prepares its first cancer and inflammatory disease drugs for the clinic. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 13, 2018 Category: Health Management Authors: Allison DeAngelis Source Type: news

Cancer-stricken mother, 40, claims the NHS is 'leaving her to die'
Emma Shaw, 40, from Rothley, Leicestershire, was diagnosed with secondary breast cancer in August - just nine months after being given the 'all clear' from the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2018 Category: Consumer Health News Source Type: news

Pancreatic cancer: The disease is the deadliest common cancer - what are the symptoms?
PANCREATIC cancer is the deadliest common cancer in the UK. In order to catch the disease early and make treatment easier, it ’s imperative to know what symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - November 13, 2018 Category: Consumer Health News Source Type: news

Business of the Year spotlight: Pink Ribbon Girls CEO Heather Salazar (Executive)
After conquering her fight with breast cancer, Heather Salazar now leads a movement of empowerment to support others in the middle of their own cancer battles. Salazar is the CEO and president of Pink Ribbon Girls, a nonprofit that provides free, accessible services for those fighting breast and gynecological cancers. Free services offered include transportation to treatment, access to healthy meals, house cleaning services and general peer support. Sal azar’s story behind Pink Ribbon Girls began… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2018 Category: Biotechnology Authors: Elizabeth Kyle Source Type: news

Medical News Today: Cancer and obesity: Clogged immune cells help explain link
A recent study examines the relationship between obesity and cancer from a new angle. The researchers look at the potential role of the immune system. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 13, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Business of the Year spotlight: Pink Ribbon Girls CEO Heather Salazar (Executive)
After conquering her fight with breast cancer, Heather Salazar now leads a movement of empowerment to support others in the middle of their own cancer battles. Salazar is the CEO and president of Pink Ribbon Girls, a nonprofit that provides free, accessible services for those fighting breast and gynecological cancers. Free services offered include transportation to treatment, access to healthy meals, house cleaning services and general peer support. Sal azar’s story behind Pink Ribbon Girls began… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2018 Category: Pharmaceuticals Authors: Elizabeth Kyle Source Type: news

Doctors Aren't Promoting Breastfeeding's Cancer-Protection Benefit
Title: Doctors Aren't Promoting Breastfeeding's Cancer-Protection BenefitCategory: Health NewsCreated: 11/12/2018 12:00:00 AMLast Editorial Review: 11/13/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 13, 2018 Category: Cancer & Oncology Source Type: news

Cancer May Soon Replace Heart Disease as Leading Killer of Affluent Americans
Title: Cancer May Soon Replace Heart Disease as Leading Killer of Affluent AmericansCategory: Health NewsCreated: 11/12/2018 12:00:00 AMLast Editorial Review: 11/13/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 13, 2018 Category: Cancer & Oncology Source Type: news

Roche's Tecentriq wins fast FDA review in tough-to-treat breast cancer
Roche's Tecentriq medicine will get a speedy review by U.S. regulators in a tough-to-treat form of breast cancer as the Swiss drugmaker seeks to be the first company to have its immunotherapy win approval in this indication. (Source: Reuters: Health)
Source: Reuters: Health - November 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA grants priority review to Roche ’s Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer
Roche today announced the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of unresectable locally advanced or metastatic triple-negative breast can cer (TNBC) in people whose disease expresses the PD-L1 protein, as determined by PD-L1 biomarker testing. (Source: Roche Media News)
Source: Roche Media News - November 13, 2018 Category: Pharmaceuticals Source Type: news

FDA grants priority review to Roche ’s Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer
Roche today announced the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of unresectable locally advanced or metastatic triple-negative breast can cer (TNBC) in people whose disease expresses the PD-L1 protein, as determined by PD-L1 biomarker testing. (Source: Roche Investor Update)
Source: Roche Investor Update - November 13, 2018 Category: Pharmaceuticals Source Type: news

2018 ESMO Immuno-Oncology Award goes to Cornelis Melief
(European Society for Medical Oncology) The European Society for Medical Oncology (ESMO) has selected Professor Cornelis Melief to receive the 2018 ESMO Immunology Award in recognition of his life's work in studying the interactions of the immune system with cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2018 Category: Cancer & Oncology Source Type: news

Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
(ECCO-the European CanCer Organisation) An antibody that binds simultaneously to two distinct regions of the HER2 receptor to block the growth of cancer cells has shown promising signs of anti-tumor activity in a number of cancers including those of the gullet (esophagus), stomach and bowel. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2018 Category: Cancer & Oncology Source Type: news

Drug designed to boost radiotherapy for hard-to-treat cancers taken safely by patients
(ECCO-the European CanCer Organisation) A new drug designed to make radiotherapy more effective in treating cancer has been given to patients while they are receiving radiation and shown to be safe, according to research presented at the 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2018 Category: Cancer & Oncology Source Type: news

New methods to identify Alzheimer's drug candidates with anti-aging properties
(Salk Institute) Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New Salk research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news